ArticleSarcoma2012

Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.

Badreddin Edris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.